Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs

Moore, T. J., Glenmullen, J., & Mattison, D. R. (2014) · JAMA Internal Medicine

Pharmacovigilance and Adverse Drug ReactionsParkinson's Disease Mechanisms and Treatments

Cited by 324

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Downing, N. S., Shah, N. D., Aminawung, J. A., Pease, A. M., Zeitoun, J.-D., Krumholz, H. M., & Ross, J. S. (2017) · JAMA

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Economics and Policy

Cited by 324

The antioxidant and radical scavenging activities of black pepper (Piper nigrum) seeds

Gülçin, İ. (2005) · International Journal of Food Sciences and Nutrition

Piperaceae Chemical and Biological StudiesPhytochemicals and Antioxidant Activities

Cited by 323

Mechanisms of drug-induced liver injury

Yuan, L., & Kaplowitz, N. (2013) · Clinics in Liver Disease

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 322

Acetaminophen-related Hepatotoxicity

Bunchorntavakul, C., & Reddy, K. R. (2013) · Clinics in Liver Disease

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 322

Novel psychoactive substances of interest for psychiatry

Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 321

Multi-cell type human liver microtissues for hepatotoxicity testing

Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 319

Metabolism of melatonin by human cytochromes p450

Ma, X., Idle, J. R., Krausz, K. W., & Gonzalez, F. J. (2005) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismCircadian rhythm and melatonin

Cited by 319

Gut reactions: Breaking down xenobiotic–microbiome interactions

Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews

Pharmacogenetics and Drug MetabolismGut microbiota and health

Cited by 319

Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry

Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 318

Strategic approaches for colon targeted drug delivery: an overview of recent advancements

Lee, S. H., Bajracharya, R., Min, J. Y., Han, J.-W., Park, B. J., & Han, H.-K. (2020) · Pharmaceutics

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 318

Drug-induced liver injury through mitochondrial dysfunction: Mechanisms and detection during preclinical safety studies

Labbe, G., Pessayre, D., & Fromenty, B. (2008) · Fundamental & Clinical Pharmacology

Drug-Induced Hepatotoxicity and ProtectionMitochondrial Function and Pathology

Cited by 317

The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review

Fabbri, A., Lai, A., Grundy, Q., & Bero, L. A. (2018) · American Journal of Public Health

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 317

The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C

Ponec, M., Weerheim, A., Kempenaar, J., Mulder, A., Gooris, G. S., Bouwstra, J., & Mieke Mommaas, A. (1997) · Journal of Investigative Dermatology

Advancements in Transdermal Drug DeliverySkin and Cellular Biology Research

Cited by 314

Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine

Renner, U. D., Oertel, R., & Kirch, W. (2005) · Therapeutic Drug Monitoring

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 314

Oxidation of Indole by Cytochrome P450 Enzymes

Gillam, E. M. J., Notley, L. M., Cai, H., De Voss, J. J., & Guengerich, F. P. (2000) · Biochemistry

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 313

Effects of smoking on the pharmacokinetics of erlotinib

Hamilton, M., Wolf, J. L., Rusk, J., Beard, S. E., Clark, G. M., Witt, K., & Cagnoni, P. J. (2006) · Clinical Cancer Research

Pharmacogenetics and Drug MetabolismLung Cancer Treatments and Mutations

Cited by 312

Pharmacogenetics of Warfarin Elimination and Its Clinical Implications

Takahashi, H., & Echizen, H. (2001) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 312

Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission

Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology

Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism

Cited by 311

Intranasal Treatment of Central Nervous System Dysfunction in Humans

Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., & Benedict, C. (2013) · Pharmaceutical Research

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 310

Progesterone and Testosterone Hydroxylation by Cytochromes P450 2C19, 2C9, and 3A4 in Human Liver Microsomes

Yamazaki, H., & Shimada, T. (1997) · Archives of Biochemistry and Biophysics

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 310

Pharmacokinetics

Fan, J., & de Lannoy, I. A. M. (2014) · Biochemical Pharmacology

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 309

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry

Andrade, R. J., Lucena, I. M., Kaplowitz, N., García-Muņoz, B., Borraz, Y., Pachkoria, K., García-Cortés, M., Fernández, C. M., Pelaez, G., Rodrigo, L., et al. (2006) · Hepatology

Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions

Cited by 309

Biocompatibility and drug delivery systems

Kohane, D. S., & Langer, R. (2010) · Chem. Sci.

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 307